These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37772442)

  • 1. Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases.
    Tefferi A; Abdelmagid M; Al-Kali A; Patnaik M; Hogan WJ; Begna K; Gangat N; Orazi A; Chen D; Reichard KK; Pardanani A
    Am J Hematol; 2024 Jan; 99(1):21-27. PubMed ID: 37772442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases.
    Shah S; Pardanani A; Elala YC; Lasho TL; Patnaik MM; Reichard KK; Hanson CA; Ketterling RP; Tefferi A
    Am J Hematol; 2018 Dec; 93(12):1461-1466. PubMed ID: 30152525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced systemic mastocytosis-Revised classification, new drugs and how we treat.
    Pardanani A; Reichard K; Tefferi A
    Br J Haematol; 2024 Feb; 204(2):402-414. PubMed ID: 38054381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models.
    Pardanani A; Shah S; Mannelli F; Elala YC; Guglielmelli P; Lasho TL; Patnaik MM; Gangat N; Ketterling RP; Reichard KK; Hanson CA; Vannucchi AM; Tefferi A
    Blood Adv; 2018 Nov; 2(21):2964-2972. PubMed ID: 30413432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin.
    Heiblig M; Gourguechon C; Guilpain P; Bulai-Livideanu C; Barete S; Chantran Y; Agopian J; Brenet F; Dubreuil P; Lespinasse J; Lemal R; Tournilhac O; Terriou L; Launay D; Bouillet L; Chatain C; Damaj G; Ballul T; Greco C; Polivka L; Frenzel L; Meni C; Bouktit H; Benabou D; Gaudy-Marqueste C; Gousseff M; Le Mouel E; Neel A; Ranta D; Jaussaud R; Molina TJ; Bruneau J; Villarese P; Lhermitte L; Maouche-Chrétien L; Temple M; Kosmider O; Javier RM; Pelletier F; Castelain F; Retornaz F; Cabrera Q; Zunic P; Gourin MP; Wierzbicka-Hainaut E; Viallard JF; Lavigne C; Hoarau C; Durieu I; Dimicoli-Salazar S; Torregrosa-Diaz JM; Wemeau M; Soria A; Arock M; Bodemer C; Lortholary O; Hermine O; Rossignol J
    Am J Hematol; 2024 Nov; 99(11):2127-2139. PubMed ID: 39287048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis.
    Tzogani K; Yu Y; Meulendijks D; Herberts C; Hennik P; Verheijen R; Wangen T; Dahlseng Håkonsen G; Kaasboll T; Dalhus M; Bolstad B; Salmonson T; Gisselbrecht C; Pignatti F
    ESMO Open; 2019 Nov; 4(6):. PubMed ID: 32392175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival.
    Pardanani A; Lasho T; Elala Y; Wassie E; Finke C; Reichard KK; Chen D; Hanson CA; Ketterling RP; Tefferi A
    Am J Hematol; 2016 Sep; 91(9):888-93. PubMed ID: 27214377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
    Pardanani A
    Am J Hematol; 2021 Apr; 96(4):508-525. PubMed ID: 33524167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.
    Pardanani A
    Am J Hematol; 2019 Mar; 94(3):363-377. PubMed ID: 30536695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases.
    Singh A; Al-Kali A; Begna KH; Litzow MR; Larsen JT; Sher T; Abdelmagid MG; Farrukh F; Reichard KK; Gangat N; Pardanani A; Tefferi A
    Am J Hematol; 2022 May; 97(5):630-637. PubMed ID: 35156231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis.
    Kasamon YL; Ko CW; Subramaniam S; Ma L; Yang Y; Nie L; Shord S; Przepiorka D; Farrell AT; McKee AE; Pazdur R
    Oncologist; 2018 Dec; 23(12):1511-1519. PubMed ID: 30115735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis.
    Kluin-Nelemans HC; Jawhar M; Reiter A; van Anrooij B; Gotlib J; Hartmann K; Illerhaus A; Oude Elberink HNG; Gorska A; Niedoszytko M; Lange M; Scaffidi L; Zanotti R; Bonadonna P; Perkins C; Elena C; Malcovati L; Shoumariyeh K; von Bubnoff N; Müller S; Triggiani M; Parente R; Schwaab J; Kundi M; Fortina AB; Caroppo F; Brockow K; Zink A; Fuchs D; Angelova-Fischer I; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Simonowski A; Sabato V; Schug T; Jentzsch M; Breynaert C; Várkonyi J; Kennedy V; Hermine O; Rossignol J; Arock M; Valent P; Sperr WR
    Theranostics; 2021; 11(1):292-303. PubMed ID: 33391475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group.
    Sotlar K; George TI; Kluin P; Reiter A; Schwaab J; Panse J; Brockow K; Hartmann K; Sperr WR; Kristensen T; Nedoszytko B; Carter M; Bonadonna P; Lyons JJ; Kluin-Nelemans HC; Hermine O; Akin C; Broesby-Olsen S; Hoermann G; Triggiani M; Butterfield JH; Jawhar M; Gotlib J; Metcalfe DD; Orfao A; Arock M; Valent P; Horny HP
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1986-1998.e2. PubMed ID: 35724949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value.
    Pardanani A; Reichard KK; Zblewski D; Abdelrahman RA; Wassie EA; Morice Ii WG; Brooks C; Grogg KL; Hanson CA; Tefferi A; Chen D
    Leukemia; 2016 Apr; 30(4):914-8. PubMed ID: 26678095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.
    Valent P; Sotlar K; Sperr WR; Escribano L; Yavuz S; Reiter A; George TI; Kluin-Nelemans HC; Hermine O; Butterfield JH; Hägglund H; Ustun C; Hornick JL; Triggiani M; Radia D; Akin C; Hartmann K; Gotlib J; Schwartz LB; Verstovsek S; Orfao A; Metcalfe DD; Arock M; Horny HP
    Ann Oncol; 2014 Sep; 25(9):1691-1700. PubMed ID: 24675021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management.
    Pardanani A
    Am J Hematol; 2023 Jul; 98(7):1097-1116. PubMed ID: 37309222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast Cell Leukemia: An Update with a Practical Review.
    Zanelli M; Quintini M; Magnasco S; Aprile L; Palicelli A; Zizzo M; Sanguedolce F; Ricci S; Pancetti S; Zuccalà V; Martino V; Broggi G; Caltabiano R; Cavazza A; Parente P; Mecucci C; Martino G; Ascani S
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries.
    Lübke J; Christen D; Schwaab J; Kaiser A; Naumann N; Shoumariyeh K; Jentzsch M; Sockel K; Schaffrath J; Ayuk FA; Stelljes M; Hilgendorf I; Sala E; Kaivers J; Schönland S; Wittke C; Hertenstein B; Radsak M; Kaiser U; Brückl V; Kröger N; Brümmendorf TH; Hofmann WK; Klein S; Jost E; Reiter A; Panse J
    Leukemia; 2024 Apr; 38(4):810-821. PubMed ID: 38448757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.